CaroGen Corporation carogencorp.com


Public lists: Pharma Startups (4733)

CaroGen provides a platform technology for generating vaccines, which is based on replication-proficient, virus-like vesicles (rVLVs) allowing target antigens to accumulate in high levels in cells, thereby amplifying specific immune responses and creating more potent immune therapies. The company, which has licensed its core technology from Yale University, will focus initially on a treatment for patients with chronic hepatitis B infections.

CaroGen provides a platform technology for generating vaccines, which is based on replication-proficient, virus-like vesicles (rVLVs) allowing target antigens to accumulate in high levels in cells, thereby amplifying specific immune responses and cre...Show all

Company (Alive / Active)

Phone: 203-815-5782

Fax:

400 Farmington Ave
room 2802
Farmington, 06036
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CaroGen Corporation $2.7M Oct 11, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CaroGen Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)